Exhibit A
Exhibit A
Pursuant to the instructions in Item 6 of Schedule 13G, the following lists the identity of each relevant entity that beneficially owns
shares of the security class being reported on this Schedule 13G.
Alpine Partners (BVI), L.P.*
*Entity that beneficially owned 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G.
The undersigned persons, on February 12, 2024, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with
their beneficial ownership of common stock of Immunome, Inc. as of December 31, 2022.
/s/ Xxx Xxxxxxx
Name: Xxx Xxxxxxx
Title: Chief Operating Officer
